Insights

Strategic Focus Privately held biotechnology therapeutics company centered on hair follicle biology and regenerative medicine, signaling potential for partnerships around wound repair and hair neogenesis platforms, including a novel device system.

Clinical Milestones Active pursuit of Phase 3 programme with plans to launch within the year, indicating imminent near-term clinical and regulatory milestones that could inform timing for co-development, licensing, or investment conversations.

Commercial Readiness Device-based treatment approach supplemented by a smartphone app concept (RAIN) suggests opportunities for hardware/software collaborations, patient engagement solutions, and digital health integrations.

Financial posture Funding of twenty-four million dollars and a recent Series B financing alongside modest current revenue (<$1M) imply a growth-focused profile with appetite for strategic partnerships, co-development, or strategic investments.

Expert Network Strong backing from PureTech Health and a cadre of dermatology, pharmaceutical, and medical device experts positions the company for channel partnerships with pharma, medtech vendors, contract research, and specialty clinics.

Similar companies to Follica, Inc.

Follica, Inc. Tech Stack

Follica, Inc. uses 8 technology products and services including Squarespace, Webpack, Squarespace Commerce, and more. Explore Follica, Inc.'s tech stack below.

  • Content Management System
  • Webpack
    Development
  • jQuery
    Javascript Libraries
  • HSTS
    Security
  • X-Content-Type-Options
    Web & Portal Technology
  • Sitelinks Search Box
    Web Tools And Plugins

Follica, Inc.'s Email Address Formats

Follica, Inc. uses at least 2 email formats:
Follica, Inc. Email FormatsExamplePercentage
FLast@follicabio.comJDoe@follicabio.com
88%
First-Last@follicabio.comJohn-Doe@follicabio.com
12%

Frequently Asked Questions

What is Follica, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Follica, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Follica, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Follica, Inc.'s official website is follicabio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Follica, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Follica, Inc.'s annual revenue is estimated to be <$1M.

What is Follica, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Follica, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Follica, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Follica, Inc. has approximately 1 employees across 1 continents, including North America. Key team members include Director Of Clinical Operations: G. B. Explore Follica, Inc.'s employee directory with LeadIQ.

What industry does Follica, Inc. belong to?

Minus sign iconPlus sign icon
Follica, Inc. operates in the Biotechnology Research industry.

What technology does Follica, Inc. use?

Minus sign iconPlus sign icon
Follica, Inc.'s tech stack includes Squarespace, Webpack, Squarespace Commerce, Microsoft 365, jQuery, HSTS, X-Content-Type-Options and Sitelinks Search Box.

What is Follica, Inc.'s email format?

Minus sign iconPlus sign icon
Follica, Inc.'s email format typically follows the pattern of FLast@follicabio.com. Find more Follica, Inc. email formats with LeadIQ.

How much funding has Follica, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, Follica, Inc. has raised $24M in funding. The last funding round occurred on Nov 08, 2010 for $135K.
Follica, Inc. logo

Follica, Inc.

Biotechnology ResearchMassachusetts, United States0-1 Employees

Follica, Inc. is a privately held biotechnology research company based in Boston, Massachusetts, focused on developing therapeutics and a novel device system for treating hair loss. The organization brings together experts in dermatology, pharmaceuticals, and medical devices to advance a platform that leverages the link between wound repair and hair follicle neogenesis, with the aim of offering new solutions for patients experiencing hair loss. Its target market includes individuals seeking hair restoration options, and the company aims to address gaps in current treatments through an integrated product platform that combines medical devices and related therapeutics. The company operates within the biotechnology and regenerative medicine sector and is positioned as a development-focused entity pursuing advancement toward commercialization. A recent development noted in industry coverage is the launch of a Phase 3 program and associated expansion of its team, alongside ongoing work on a smartphone app related to its RAIN treatment, reflecting continued progress in its pipeline and ecosystem. } }{ } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
0-1

Section iconFunding & Financials

  • $24M

    Follica, Inc. has raised a total of $24M of funding over 4 rounds. Their latest funding round was raised on Nov 08, 2010 in the amount of $135K as a Series B.

  • <$1M

    Follica, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.